(Q36077858)

12 August 2017

1 reference

title

High sensitivity C-reactive protein in clinical practice (English)

1 reference

12 August 2017

2

Paul M Ridker

1 reference

12 August 2017

José L Torres

1

1 reference

12 August 2017

publication date

1 January 2003

1 reference

The American heart hospital journal

12 August 2017

published in

1 reference

12 August 2017

volume

1

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

207-211

1 reference

Atherosclerosis — An Inflammatory Disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Leucocyte-endothelial interactions and regulation of leucocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-reactive protein and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

The effect of aspirin on C-reactive protein as a marker of risk in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

Elevated C-reactive protein levels in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

P-Selectin and Vascular Cell Adhesion Molecule-1 Are Focally Expressed in Aortas of Hypercholesterolemic Rabbits Before Intimal Accumulation of Macrophages and T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2003.02109.X

10.1111/J.1541-9215.2003.02109.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference